Ashiq Mubarack

Item: Ashiq Mubarack
Rating: 0.87
Author: StockAnalysis.com

Stock Analyst at Citigroup

(0.87)

# 3,890

Out of 4,981 analysts

Total ratings

66.67%

Success rate

-18.49%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Ashiq Mubarack

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MRSN Mersana Therapeutics	Maintains: Buy	$150 → $125	$7.14	+1,650.70%	2	Aug 27, 2024
	DRTS Alpha Tau Medical	Initiates: Buy	$8	$3.82	+109.42%	1	Dec 15, 2023

Mersana Therapeutics

Aug 27, 2024

Maintains: Buy

Price Target: $150 → $125

Current: $7.14

Upside: +1,650.70%

Alpha Tau Medical

Dec 15, 2023

Initiates: Buy

Price Target: $8

Current: $3.82

Upside: +109.42%